Trish Dring

Trish Dring currently serves as Deputy General Counsel at MacroGenics, Inc. since September 2021, having previously held the position of Vice President, Associate General Counsel at Aurinia Pharmaceuticals Inc. from September 2020 to September 2021. Dring's career at MacroGenics also includes a role as Associate General Counsel from August 2018 to September 2020. Prior to that, Dring was Vice President, Associate General Counsel at United Therapeutics from February 2017 to August 2018 and Executive Director of Access Strategy & Programs at AstraZeneca from 2013 to February 2017. Dring began legal career as Senior Counsel at MedImmune from 2001 to 2013 and has earlier experience as a Chemist at Chesapeake Biological Lab. Dring holds a JD from the University of Maryland Francis King Carey School of Law, a Master’s degree in Analytical Chemistry from the University of Maryland, and a Bachelor's degree in Analytical Chemistry from Binghamton University.